Home Cart Sign in  
Chemical Structure| 250612-42-1 Chemical Structure| 250612-42-1

Structure of Cyclo(RGDyK) trifluoroacetate
CAS No.: 250612-42-1

Chemical Structure| 250612-42-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cyclo(RGDyK) is a highly potent and selective inhibitor for the αvβ3 integrin with a IC50 of 0.94 nM.

Synonyms: Cyclo(RGDyK)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cyclo(RGDyK) trifluoroacetate

CAS No. :250612-42-1
Formula : C31H43F6N9O12
M.W : 847.72
SMILES Code : O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C[C@@H](C(N[C@H](CC1=CC=C(O)C=C1)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(NC2)=O)=O)=O)=O)NC2=O
Synonyms :
Cyclo(RGDyK)
MDL No. :MFCD20134101

Safety of Cyclo(RGDyK) trifluoroacetate

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H319-H332-H372-H400
Precautionary Statements:P260-P264-P270-P273-P280-P301+P312+P330-P304+P312-P305+P351+P338-P314-P337+P313-P391-P501
Class:9
UN#:3077
Packing Group:

Related Pathways of Cyclo(RGDyK) trifluoroacetate

cytoskeleton

Isoform Comparison

Biological Activity

Target
  • Integrin

    αVβ3 integrin, IC50:20 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
MLO-Y4 cells 10nM 10 min Cyclo(RGDyK) prevented the irisin-mediated phosphorylation of FAK PMC6298040
human mesenchymal stem cells (hMSCs) 0.1, 0.25, 0.5, 1 mM 1 h Improved cell-matrix interactions, enhanced cell spreading and metabolic activity PMC7667870
A375 cells 10 μM 2 h To evaluate the inhibition of ERK phosphorylation by RGD-MEKI conjugates PMC6269693
U87 cells 10 μM 24 h To evaluate the inhibition of U87 cell proliferation by RGD-MEKI conjugates PMC6269693

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
mice wild-type mice intraperitoneal injection 1mg/kg daily for 6 days Cyclo(RGDyK) prevented the irisin-induced gene expression of sclerostin PMC6298040
Rat Chronic ocular hypertension model Intravitreal injection 20 nM Every other week for 4 weeks After blocking OPN receptors, the autophagy activity in retinal Müller cells significantly increased, and RGCs survival was enhanced PMC10213002

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.18mL

0.24mL

0.12mL

5.90mL

1.18mL

0.59mL

11.80mL

2.36mL

1.18mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories